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Introduction
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Along with rapid socio-economic and lifestyle changes during the past decades in China, the prevalence of 34 chronic non-communicable diseases (NCDs) has increased dramatically 1,2 . Accumulating evidence from 35 epidemiology studies has revealed age-related sex differences in life expectancy, and in risk, course, and 36 outcomes of NCDs 3,4 . Paradoxically, women live longer, but are predisposed to higher incidences and worse 37 outcomes of certain diseases than age-matched men in late life, such as cardiometabolic disorders and 38
Alzheimer's disease [5] [6] [7] [8] . 39
In spite of increasing evidence pointing to associations between the gut microbiota and NCDs 9-12 , much 40 remains unknown in relation to sexual dimorphism in the gut microbiota as well as possible interactions with 41
Sex differences in gut microbial composition and functionality
93
To investigate the importance of covariates in the PG cohort, PERMANOVA was applied for host 94 phenotypes collected through clinical measurements and questionnaires (Fig. 1a, Methods) . In the entire 95 analysis cohort, 42 factors were identified as significant covariates impacting on the gut microbiota, 96 including sex, age, serum triglyceride (TG), uric acid (UA), testosterone levels, waist-to-hip ratio (WHR), 97 body mass index (BMI), and male characteristic lifestyles, including intake of alcohol and smoking 98 (PERMANOVA, adjusted P < 0.05, Fig. 2a , Supplementary Table 4-6). Interestingly, sex explained the 99 largest gut microbial variance in the PG cohort (Fig.2a) , whereas sex was found to rank lower than other 100 commonly identified covariates such as TG, UA and BMI in previous large-scale studies 20, 26, 27 . 101 (deoxycholic acid (DCA) and hyodeoxycholic acid (HDCA)) in women, contrasted by higher levels of 126 chenodeoxycholic acid (CDCA) and ursodeoxycholic acid (UDCA), and a larger total BA pool in men (Fig.  127   2e, Extended Data Fig. 3, Supplementary Table 8) . 128
In summary, our results revealed substantial population independent and dependent sex differences in the gut 129 microbial composition and functional capacity. 130 association patterns characterised women and men. Surprisingly, many sex-biased covariates, includingHbA1c and WHR in women, but positively with liver aminotransferase levels rather than any diabetes or 169 obesity-related parameters in men (Fig. 3e, g, Extended Fig. 5 ). Although several Streptococcus spp. have 170 been reported to be enriched in elderly European women with T2D compared to women with normal orobserved sex-biased disease associations.digestive system and the immune system, and increased multimorbidity and medicine use [34] [35] [36] [37] . However, 176 reported ageing-related gut microbial characteristics are variable and inconsistent 38 , potentially confounded 177 by ageing-related health conditions, sample size, and sex.gut microbiota of adults below and above 50 years in each sex (Methods). In line with the higher impact of 180 age on the overall gut microbiota composition in men, we also observed that the magnitude of differences in 181 microbial α diversity and the proportions of differentially abundant species and functional KOs between 182 younger and elderly individuals were greater in men compared to women (Fig. 4a-b and to a greater extent in men than in women (Extended Data Fig. 8, Supplementary Table 15 ). Given the 193 clinical links established between increased methane production and prolonged intestinal transit time 39, 40 , an 194 age-related increase in methane production might be related to increased chronic constipation in elderly. A 195 second round Permanova analysis further revealed significant impacts of age and obesity-related covariates 196 (obesity, BMI and WHR) on species that differed in abundance between the two age groups in both sexes, 197 but in opposite directions (Extended Data Fig. 7b-c) . The sex-dependent opposite effects of these 198 obesity-related covariates on the microbiota were consistent with the age-and sex-dependent disparities in 199 metabolic disorders (Extended Data Fig. 7d, e) . Most blood routine parameters and dietary patterns that 200 differed significantly between the two age groups (Supplementary Table 3 showed no significant effects (Extended Data Fig. 7b) . 202
With the purpose of estimating how strong the gut microbiota might be related to host chronological age, we 203 used gut microbial species to build age prediction models in each sex (Methods) 41 . Interestingly, models inboth sexes in the PG cohort had good performances, with a relatively higher Spearman's rho of 0.584 for 205 men compared with 0.436 for women between predicted and actual age (Fig. 4c) . Of the models for both 206 sexes, the accumulated local effects (ALE) of most selected features were consistently increasing or 207 decreasing with the predicted ages, but with larger effects in men (Fig. 4d) . The ALE ranges of selected 208 species features were also sex-biased in the age-prediction models for the LLD cohort (Extended Data Fig.  209 6d-e). Interestingly, A. muciniphila, Eubacterium siraeum and Coprococcus catus, were selected as strong 210 positive age predictors only for adult men in both cohorts (ALE range ≥ 1 year) (Fig. 4d, Extended Data Fig.  211 6e). The elderly enriched species Streptococcus gordonii predicted increased average age in both cohorts and 212 was selected as the strongest age predictor for the LLD adults (Fig. 4d, Extended Data Fig. 6e) . Although 213 the abundances of several Bifidobacterium species were decreased in elderly of both cohorts, B. adolescentis 214 and B. longum were stronger predictors in the PG cohort, whereas B. bifidum and B. animals more strongly 215 predicted age in the LLD cohort (Fig. 4d, Extended Data Fig. 6e) . 216
Additionally, we found significant differences in the abundance of many sex-biased species between age 217 groups. Of note, the abundances of multiple women enriched species were relatively stable among adult 218 women across broad age ranges, but showed significant increases in elderly men as compared to young men 219 (Fig. 4d) . This raised the question as to whether sex-associated microbial differences were reduced in elderly. 220
In both the PG and the LLD cohorts, sex indeed explained much less of the microbial variances in elderly 221 individuals (Fig. 5a, c, Supplementary Table 18) , and the number of sex-dependent differences in 222 microbial features was considerably less in elderly compared with younger adults (Fig. 5b, d ). For instance, 223 55 and 41 species whose abundance differed between adult women and men of younger age in the PG and 224 the LLD cohort respectively (adjusted P < 0.05, Fig. 5b,d, e) , showed no significant sex difference in 225 elderly ((adjusted P > 0.05, Fig. 5b,d, f) . On the other hand, we found that 38 species differed consitently in 226 abundance between men and women in both age groups in the PG cohort (Fig. 5f) . Among them, several 227
were correlated with intake of alcohol or smoking in PG men (Fig. 5f) . For instance, intake of alcohol in 228 men correlated negatively with the abundance of women enriched species, such as B. adolescentis, R. 229 champanellensis and A. shahii, but positively with men-enriched species Turicibacter sanguinis after 230 adjusting for age, BMI, and smoking (Fig. 5f , Partial Spearman's correlation, adjusted P < 0.05). 231
Smoking also negatively correlated with several women-enriched bacteria, including E. eligens, E.microbiota as well as the potential relation to diseases and behaviour, has often been overlooked. Our study 238 demonstrates the sexual dimorphism in the gut microbiome and associations with age, sex hormones, and 239 other host metadata in a large community-based cohort randomly drawn from a Northern Chinese Han 240 population. 241
The women in the PG cohort harboured a relatively more diverse and richer gut microbial community than 242 that of men, a finding which was further replicated in published datasets of Chinese and Dutch adults. Of 243 note, both Chinese and Dutch adult women exhibited a significant enrichment of A. muciniphila, a 244 well-characterized metabolic beneficial species 42, 43 , and E. lenta. The latter species possesses the ability to 245 inactivate digoxin 44 , the therapeutic effect of which has been reported to differ between women and men 45 . 246
Significant sex differences were also consistently observed in the abundance of bacterial genes involved in 247 BA transformation and in serum BA profiles, suggesting that the gut microbiota might modulate sex-biased 248 host metabolic processes through BA-Farnesoid X receptor (FXR) and TGR5 signalling pathways. These 249 sex differences of the gut microbiota might potentially be associated with the age-related sex disparities in 250 risk, pathophysiology and treatment of metabolic disorders, where the underlying mechanisms require 251 further investigation. 252
Focusing on the host-microbiome association patterns in the PG cohort, we show that the overall gut 253 microbial community in women seemed to remain relatively stable between different age groups, while it in 254 men varied significantly with age, testosterone levels, multiple metabolic parameters, and lifestyle. 255 Correspondingly, many species including several butyrate producers were positively correlated with 256 testosterone levels in men but showed negligible relationships with sex hormone levels in women. 257
Additionally, smoking and alcohol intake in men were negatively associated with several women enriched 258 bacterial species, suggesting that the sexual dimorphism of the gut microbiota might be mediated through 259 both hormone-dependent and -independent factors.of the population in the area. The overall research objectives of the Pinggu cohort are to study the 326 involvement of genetic and environmental factors in the development of metabolic diseases and to 327 understand the changes/roles of the gut microbiota on the ageing process. 328
Based on the national Civil Registration system, a total of 6,583 participants were randomly drawn using 329 multistage stratified sampling method according to the demographic structure in terms of sex, age and region 330 (rural or suburban) (Fig. 1a) . Participants were eligible based on the following criteria: 1) born in Pinggu; 2) 331 5 years or longer continuous residence in Pinggu back tracing from the sampling point, and 3) adults aged 332 26-76 years (men and non-pregnant women). A total of 4,002 individuals were enrolled, giving a response 333 rate of 60.8%. All enrolled participants signed an informed consent form before their physical examination 334 and biomaterial collection. Subsequently, 2,338 participants meeting the additional criteria: 1) with faecal 335 and blood samples; 2) with complete questionnaire information; 3) without antibiotic treatment in the past 3 336 weeks before biomaterial collections, and 4) without severe disease (end-stage cancer and renal disease), 337
were selected for the metagenomic study. In total, 98 phenotypic factors were collected for each participants 338 through questionnaires (Q), including socio-demographics (n=5), lifestyle (n=4), diet (n=18), drugs for 339 treating metabolic disorders when collecting faecal samples (n=10), and female gynaecological information 340 DNA extraction from faecal samples was performed as previously described 9 . 398 DNA nanoball (DNB) based DNA library construction and combinatorial probe-anchor synthesis (cPAS) 399 based shotgun metagenomic sequencing with 100bp single-end reads were applied to all 2,338 400 samples (MGI, Shenzhen, China). Quality control (QC) workflow developed for this platform was applied to 401 filter out low-quality and human reads 62 . On average 6.9 Gb (± 2.1 Gb) high-quality data was generated per 402 sample. High-quality non-human reads were further aligned to the 9.9M integrated gene catalogue (IGC) 28 . 403
To control for the quantitative biases of fluctuations in sequencing depth, the IGC uniquely mapped reads 404 were downsized to 20 million for each sample and then used to generate the relative abundance profiles of 405
Impacts of drugs 455
Of the 2,338 individuals, 597 (25.5%) were taking at least one type of drugs for treating diabetes, 456 hypertension or dyslipidaemia around the time for donating faecal sample (Supplementary Table 2 ). Of 457 these drugs registered in the PG cohort, ten with at least 20 users, including antidiabetic drugs (biguanides, 458 glucosidase inhibitors (GIs), sulphonylureas and glinides), antihypertensive drugs (calcium channel blockers 459 (CCBs), beta-adrenergic receptor blockers (beta blockers), diuretics, angiotensin II receptor blockers 460 (ARBs), angiotensin-converting enzyme inhibitors (ACEIs)), and statins for dyslipidaemia, were used for 461
analyses. 462
To evaluate the impacts of each type of the ten drugs on the gut microbiota, we conducted multiple rounds of 463 PERMANOVA analyses based on Bray-Curtis dissimilarities at the gene, species, and KO level. 464 PERMANOVA analyses were conducted using the function adonis from the vegan R package. R-squared 465 (R 2 ) was adjusted for the number of observations and the number of degrees of freedom using the function 466
RsquareAdj from the same package. The P value was determined by 10,000 permutations and was further 467
adjusted for multiple testing of tested drugs in each round using Benjamini-Hochberg (BH) method 468 (function p.adjust, package stats) 66 . An adjusted P value smaller than 0.05 was considered statistically 469 significant. For each round, 1,741 participants not using any of the registered drugs were used as treatment 470 naive controls. In the first round, for a given drug, PERMANOVA was performed on datasets from 471 participants taking it alone or in combination with others and treatment native controls. Drugs such as 472 biguanides, GIs, glinides, sulphonylureas, ARBs and statins were identified to be of significance (adjusted P 473 < 0.05, Supplementary Table 2). In the next round, samples from participants taking biguanides and/or GIs, 474 which showed the most significant impacts on the overall gut microbial variations in the first round, were 475 excluded. The effect remained significant for ARBs and statins, but not for glinides and sulphonylureas. In 476 the last round, PERMANOVA was performed on samples from individuals taking only one type of drug and 477 treatment naive controls to evaluate the standalone effect of the drug. Of the drugs that significantlyinfluenced the composition of the gut microbiota identified above, GIs were not evaluated in this round dueto a shortage of samples, and no other drugs than biguanides were still found to significantly impact on the 
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